Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency
Sara Barmettler, Daniel DiGiacomo, Nancy Yang, Tiffany Lam, Vivek Naranbhai, Anand S. Dighe, Kristin E. Burke, Kimberly G. Blumenthal, Morris Ling, Paul E. Hesterberg, Rebecca R. Saff, James A. MacLean, Onosereme Ofoman, Cristhian Berrios, Kerri St. Denis, Evan C. Lam, David J. Gregory, A. John Iafrate, Mark C. Poznansky, Hang Lee, Alejandro B. Balazs, Shiv Pillai, Jocelyn R. Farmer
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRespiratory systemCoronavirusAntibodyBetacoronavirusVirologyImmunologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Immunodeficiency and Autoimmune DisordersSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies